The investment was larger than his trades in more established pharmaceutical stocks like Pfizer and Merck. With his discount from the private placements, Mr. Price would have purchased some stock at 25 Australian cents per share in August and some at 34 cents. The stock closed on Friday at $1. 31. Mr. McAdams, Mr. Collinsâ€™s spokesman, said the private placement was available to qualified American investors and said Mr. Hook had previously invested in a private placement with the company in 2009, before Mr. Collins was a congressman. 